Treatment of the Blastic Crisis of Chronic Myelogenous Leukemia with the Combination of Vindesine and Prednisolone, and Cytosine Arabinoside

UZUKA, Y. and SAITO, Y. Treatment of the Blastic Crisis of Chronic Myelogenous Leukemia with the Combination of Vindesine and Predonisolone, and Cytosine Arabinoside. Tohoku J. exp. Med., 1983, 139 (4), 419-420 -Sixteen patients with chronic myelogenous leukemia in blast crisis were classified into...

Full description

Saved in:
Bibliographic Details
Published inThe Tohoku Journal of Experimental Medicine Vol. 139; no. 4; pp. 419 - 420
Main Authors UZUKA, YOSHIRO, SAITO, YOSHIKO
Format Journal Article
LanguageEnglish
Published Japan Tohoku University Medical Press 01.01.1983
Subjects
Antineoplastic Agents - therapeutic use
blast crisis
chronic myelogenous leukemia
Cytarabine - therapeutic use
Drug Therapy, Combination
Humans
Leukemia, Myeloid - drug therapy
Leukemia, Myeloid - pathology
Prednisolone - therapeutic use
Vinblastine - analogs & derivatives
Vinblastine - therapeutic use
Vindesine
Online AccessGet full text

Cover

More Information
Summary:UZUKA, Y. and SAITO, Y. Treatment of the Blastic Crisis of Chronic Myelogenous Leukemia with the Combination of Vindesine and Predonisolone, and Cytosine Arabinoside. Tohoku J. exp. Med., 1983, 139 (4), 419-420 -Sixteen patients with chronic myelogenous leukemia in blast crisis were classified into three subgroups on the basis of blast cell morphology and a relation to the chemotherapeutic responsiveness was investigated. All of the four patients with lymphoid morphology, and seven of the eight with myeloid morphology (88%) achieved complete remission while none of the four with monocytoid morphology achieved complete remission.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0040-8727
1349-3329
DOI:10.1620/tjem.139.419